Fresenius SE & Co KGaA (FRE)

Industry Medical Care Facilities


This stock can be held in an Investment ISA and an Investment Account
Sell

€47.52

Buy

€47.53

arrow-down€-1.07 (-2.21%)

Prices updated at 16 Dec 2025, 16:35 CET
| Prices minimum 15 mins delay
|
Prices in EUR

Fresenius SE & Co KGaA is a holding company engaged in healthcare business. It provides dialysis machines, and manufactures equipment for Medical Care through its subsidiaries. The company also manufactures IV drugs, clinical nutrition, and infusion.

Income statement

20232024
21,067m21,833m
4,971m5,378m
1,183m1,782m
5.628.16
-594m471m
2,692m3,139m
Sales, General and administrative3,027m2,919m
Interest expenses519m547m
Provision for income taxes485m521m
Operating expenses3,788m3,596m
Income before taxes773m1,388m
Net income available to common shareholders-594m471m
-1.050.84
Net interest income-398m-432m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-1.050.84
Free cash flow per share3.95574.0853
Book value/share35.569433.4264
Debt equity ratio0.6973520.552912

Balance sheet

20232024
Current assets12,520m11,446m
Current liabilities9,330m9,009m
Total capital30,456m29,019m
Total debt15,830m13,577m
Total equity18,999m19,542m
Total non current liabilities--
Loans11,457m9,477m
Total assets45,284m43,550m
Total liabilities--
Cash and cash equivalents2,289m2,046m
Common stock563m563m

Cash flow

20232024
Cash at beginning of period2,749m2,562m
Cash dividends paid-550m-
3,322m1,524m
Investments (gains) losses-3,187m-510m
2,562m2,282m
Net income--
4,456m2,447m
-1,134m-923m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.